-
Jan 8, 2025 | 
dx.doi.org | Antoine Elie |Yann Niberon |Aurélien BRUYANT |Laurent Arnaud
-
Nov 13, 2024 | 
nature.com | Kirk M Druey |Laurent Arnaud |Samir Parikh
AbstractThe vascular endothelial barrier maintains intravascular volume and metabolic homeostasis. Although plasma fluids and proteins extravasate continuously from tissue microvasculature (capillaries, post-capillary venules), systemic vascular leakage increases in critical illness associated with sepsis, burns and trauma, among others, or in association with certain drugs or toxin exposures.
-
Nov 1, 2024 | 
jrheum.org | Graciela S. Alarcón |Laurent Arnaud |Guillermo Javier Pons-Estel |Romina Estefanía Nieto
The article by Tani et al, “Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study,”1 evaluates the efficacy of anifrolumab (ANI) in patients with systemic lupus erythematosus (SLE) who failed to respond to other treatments, including biologics. There are many unmet needs in the treatment of SLE.
-
May 15, 2024 | 
ard.bmj.com | Ioannis Parodis |Charlotte Girard-Guyonvarc’h |Laurent Arnaud |Oliver Distler
Based on the results from the SLR and mainly driven by the overall CA, but also expert opinion, overarching principles and recommendation statements were proposed by the steering committee and were presented and discussed with the task force members at four consecutive online meetings in May and June 2022. In these meetings, 23, 20, 17 and 16 of 25 task force members participated, respectively.
-
Apr 21, 2024 | 
insu.hal.science | Maxim Lamare |Jesús Revuelto |Maude Pelletier |Laurent Arnaud
Article Dans Une Revue Journal of Hydrometeorology Année : 2023 Investigating the Role of Shrub Height and Topography in Snow Accumulation on Low-Arctic Tundra using UAV-Borne Lidar Fichier sous embargo 0 ― 1 ― 0 Année Mois Jours Avant la publication mardi 21 mai 2024 insu-04471098 , version 1 (21-04-2024) Maxim Lamare, Florent Domine, Jesús Revuelto, Maude Pelletier, Laurent Arnaud, et al..
-
Apr 17, 2024 | 00398-2/abstract?rss=yes&sz=64)
thelancet.com | Alberta Y Hoi |Talia Igel |Chi Chiu Mok |Laurent Arnaud
1. Tian J Zhang D Yao X Huang Y Lu Q Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2023; 82: 351-3562. Carter EE Barr SG Clarke AE The global burden of SLE: prevalence, health disparities, and socioeconomic impact. Nat Rev Rheumatol. 2016; 12: 605-6203. Barber MRW Drenkard C Falasinnu T et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021; 17: 515-5324.
-
Feb 15, 2024 | 
lupus.bmj.com | Laurent Arnaud |Ioannis Parodis |Hervé Devilliers |Francois Chasset
Clinical trial outcomes for SLE: what we have and what we need Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
-
Feb 9, 2024 | 
slate.fr | Laurent Arnaud |Etienne Gourlay
Avec la montée des préoccupations environnementales et la nécessité de réduire les émissions de gaz à effet de serre (GES), l'usage des matériaux biosourcés dans le domaine du bâtiment, aussi bien en construction neuve qu'en rénovation, devrait connaître une forte croissance dans les années à venir. Les matériaux biosourcés sont des matériaux issus de la matière organique renouvelable (biomasse) d'origine végétale ou animale.
-
Feb 8, 2024 | 
theconversation.com | Laurent Arnaud |Etienne Gourlay
Avec la montée des préoccupations environnementales et la nécessité de réduire les émissions de gaz à effet de serre, l’usage des matériaux biosourcés dans le domaine du bâtiment, aussi bien en construction neuve qu’en rénovation, devrait connaître une forte croissance dans les années à venir. Les matériaux biosourcés sont des matériaux issus de la matière organique renouvelable (biomasse) d’origine végétale ou animale.
-
Dec 20, 2023 | 
lupus.bmj.com | Laurent Arnaud |Richard A. Furie |Eric F. Morand |Martin Aringer
DiscussionSPOCS is a prospective, observational study designed to analyse clinical outcomes over time of a large, real-world cohort of patients with moderate-to-severe SLE. Overall, this study identified substantial clinical burden in a broadly representative group of patients with moderate-to-severe SLE in a real-world setting, including long disease duration and presence of organ damage in more than half of patients.
